Evidence map›Paper›PMID 31046246›Full record

ArticleChemical research in toxicology2019

Anatoly Zhitkovich

Open access · bronzeAbstract read
In one paragraph

Article in Chemical research in toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 182 citations in OpenAlex.

  1. Trial
  2. Article
  3. β-Thujaplicin modulates the ODC-ROS-linked apoptosis in H460 lung cancer cells.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  4. Article
  5. Article
  6. The Scavenger Function of LSECs, a Regulator of Liver Diseases.Current issues in molecular biology · 2026
    Review
  7. Article
  8. Antioxidants (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anatoly ZhitkovichDepartment of Pathology and Laboratory Medicine , Brown University , 70 Ship Street , Providence , Rhode Island 02912 , United States.ORCID 0000-0001-9007-2400
Brown University · US

Funding

GENOTOXICITY OF CHROMIUM COMPOUNDSR01ES008786 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZHITKOVICH, ANATOLY · 1997 to 2019
$5.7M
Formaldehyde GenotoxicityR01ES020689 · NIEHS · BROWN UNIVERSITY · PI ZHITKOVICH, ANATOLY · 2012 to 2016
$2.0M
Regulation of p53 and Checkpoint Signaling by Chromium(VI)R01ES028072 · NIEHS · BROWN UNIVERSITY · PI ZHITKOVICH, ANATOLY · 2018 to 2022
$1.8M
NIEHS NIH HHS R01 ES008786NIEHS NIH HHS R01 ES020689NIEHS NIH HHS R01 ES028072
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetylcysteineAldehydesDisulfidesFree Radical ScavengersMetals, HeavyOxidation-ReductionReactive Oxygen SpeciesAcetylcysteineAldehydesDisulfidesFree Radical ScavengersMetals, HeavyReactive Oxygen Species

Identifiers

PMID31046246
PMCPMC6757335
OpenAlexW2942950983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.